| Title |
What is the evidence base for diagnosing hypertension and for subsequent blood pressure treatment targets in the prevention of cardiovascular disease?
|
|---|---|
| Published in |
BMC Medicine, October 2015
|
| DOI | 10.1186/s12916-015-0502-5 |
| Pubmed ID | |
| Authors |
Claire L. Schwartz, Richard J. McManus |
| Abstract |
Diagnosing and treating hypertension plays an important role in minimising the risk of cardiovascular disease and stroke. Early and accurate diagnosis of hypertension, as well as regular monitoring, is essential to meet treatment targets. In this article, current recommendations for the screening and diagnosis of hypertension are reviewed. The evidence for treatment targets specified in contemporary guidelines is evaluated and recommendations from the USA, Canada, Europe and the UK are compared. Finally, consideration is given as to how diagnosis and management of hypertension might develop in the future. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Science communicators (journalists, bloggers, editors) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 112 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Kenya | 1 | <1% |
| Unknown | 110 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 24 | 21% |
| Student > Bachelor | 14 | 13% |
| Student > Master | 11 | 10% |
| Student > Postgraduate | 8 | 7% |
| Student > Ph. D. Student | 8 | 7% |
| Other | 19 | 17% |
| Unknown | 28 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 52 | 46% |
| Nursing and Health Professions | 14 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
| Psychology | 4 | 4% |
| Biochemistry, Genetics and Molecular Biology | 2 | 2% |
| Other | 7 | 6% |
| Unknown | 29 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 July 2020.
All research outputs
#2,375,848
of 22,834,308 outputs
Outputs from BMC Medicine
#1,535
of 3,430 outputs
Outputs of similar age
#35,214
of 279,100 outputs
Outputs of similar age from BMC Medicine
#51
of 86 outputs
Altmetric has tracked 22,834,308 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,430 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 43.6. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 279,100 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 86 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.